Ci Investments Inc. Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Ci Investments Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$144.95 - $152.29 $289 - $304	-2 Reduced 2.17%	90 $14,000
Q2 2022 Aug 12, 2022	SELL	$83.14 - $145.99 $16,129 - $28,322	-194 Reduced 67.83%	92 $13,000
Q1 2022 May 12, 2022	SELL	$110.08 - $142.92 $2,531 - $3,287	-23 Reduced 7.44%	286 $34,000
Q4 2021 Feb 11, 2022	SELL	$99.73 - $148.48 $420,860 - $626,585	-4,220 Reduced 93.18%	309 $43,000
Q3 2021 Nov 12, 2021	BUY	$98.85 - $138.91 $447,691 - $629,123	4,529 New	4,529 $629,000
Q1 2021 May 13, 2021	SELL	$64.07 - $91.75 $389,033 - $557,106	-6,072 Closed	0 $0
Q4 2020 Feb 09, 2021	BUY	$65.07 - $98.24 $395,105 - $596,513	6,072 New	6,072 $520,000

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Ci Investments Inc., based on Form 13F filings with the SEC.

Stay updated on Ci Investments Inc. with notifications on news.